Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer (Q43128963)

From Wikidata
Jump to navigation Jump to search
scientific article published on 16 March 2010
edit
Language Label Description Also known as
English
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer
scientific article published on 16 March 2010

    Statements

    Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer (English)
    Kyle E Rusthoven
    Steven J Feigenberg

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit